Beckman Coulter Profit Falls on Higher Costs
From Reuters
Beckman Coulter Inc. said its second-quarter profit fell on higher expenses and a decline in sales in Japan and China.
The Fullerton maker of laboratory equipment, genetic testing kits and products used in drug discovery posted net income of $44.6 million, or 70 cents a share, down from $55.2 million, or 85 cents, a year ago. Sales fell to $616.3 million from $618.8 million last year.
Beckman revised its outlook downward for the rest of the year to reflect slow growth in Asia.
